Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Chinese Patent Office
Fuji
AstraZeneca
Express Scripts
Covington
Queensland Health
Dow
Colorcon

Generated: April 22, 2018

DrugPatentWatch Database Preview

PONSTEL Drug Profile

« Back to Dashboard

When do Ponstel patents expire, and what generic alternatives are available?

Ponstel is a drug marketed by Shionogi Inc and is included in one NDA.

The generic ingredient in PONSTEL is mefenamic acid. There are thirteen drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the mefenamic acid profile page.
Drug patent expirations by year for PONSTEL
Pharmacology for PONSTEL
Medical Subject Heading (MeSH) Categories for PONSTEL
Synonyms for PONSTEL
1-Methyl-3-benzylimidazolium tetrafluoroborate
2-((2,3-Dimethylphenyl)amino)benzoic acid
2-(2,3-Dimethyl-phenylamino)-benzoic acid
2-(2,3-Dimethyl-phenylamino)-benzoic acid(Mefenamic acid)
2-(2,3-Dimethylanilino)benzoic acid
2-(2,3-Dimethylanilino)benzoic acid #
2-(2,3-dimethylphenylamino)benzoic acid
2-(2,3-Xylidino)benzoic Acid
2-[(2,3-dimethylphenyl) amino]benzoic acid
2-[(2,3-dimethylphenyl)amino]benzoic acid
2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-
2-Diphenylaminecarboxylic acid,3'-dimethyl-
367589PJ2C
4-methyl-N-(3-{3-[(4-methylpiperidin-1-yl)carbonyl]imidazo[2,1-b][1,3]thiazol-6-yl}phenyl)benzenesulfonamide
61-68-7
A1077/0050549
A833367
AB00052200
AB00052200_18
AB00052200_19
AB00052200-17
AB0012318
AB1009470
AC-11160
Ac. mefenamico
Ac. mefenamico [Italian]
AC1L1HAE
AC1Q2NNQ
Acide mefenamique
Acide mefenamique [French]
Acide mefenamique [INN-French]
Acido mefenamico
Acido mefenamico [INN-Spanish]
Acidum mefenamicum
Acidum mefenamicum [INN-Latin]
AGN-1255
AJ-08418
AK-72920
AKOS001025551
AKOS002388313
ALBB-025759
AM20060688
AN-23714
Anthranilic acid, N-(2,3-xylyl)-
Anthranilic acid, N-2,3-xylyl-
Anthranilic acid,3-xylyl-
AS-12677
Bafameritin-M
Bafhameritin-M
BBL003564
BC201828
BDBM50134036
Benzoic acid, 2-((2,3-dimethylphenyl)amino)-
Benzoic acid, 2-(2,3-dimethylphenyl)amino-
Benzoic acid, 2-[(2,3-dimethylphenyl)amino]-
Benzoic acid,3-dimethylphenyl)amino]-
Bonabol
BPBio1_000229
BR-72920
BRD-8217
BRD-K92778217-001-06-1
BRD8217
BRN 2216243
BSPBio_000207
BSPBio_002724
C02168
CAS-61-68-7
CCG-39434
CHEBI:6717
CHEMBL686
CI 473
CI-473
cid_4044
CL 473
CN 35355
CN-35355
Coslan
CPD000058188
CS-2681
D00151
D05FTJ
DB00784
DivK1c_000298
DSSTox_CID_3243
DSSTox_GSID_23243
DSSTox_RID_76938
DTXSID5023243
Dyfenamic (TN)
EINECS 200-513-1
F0850-6853
FT-0628184
Godecke Brand of Mefenamic Acid
GTPL2593
HL 1
HMS1568K09
HMS1921D13
HMS2090B07
HMS2092B17
HMS2095K09
HMS2232P18
HMS3259M19
HMS3370K18
HMS3652A10
HMS500O20
HSDB 3115
HY-B0574
HYYBABOKPJLUIN-UHFFFAOYSA-N
I14-3644
ID8
IDI1_000298
in-M
InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18
INF 3355
INF-3355
KBio1_000298
KBio2_000654
KBio2_003222
KBio2_005790
KBio3_001944
KBioGR_001730
KBioSS_000654
KS-00000WDA
LS-20589
Lysalgo
M-6454
M1782
Mafepain (TN)
MCULE-1031776135
Mefacit
Mefanamic acid
Mefedolo
Mefenacid
Mefenamate
mefenamic acid
Mefenamic acid (JP17/USP/INN)
Mefenamic acid [USAN:INN:BAN:JAN]
Mefenamic acid [USAN:USP:INN:BAN:JAN]
Mefenamic acid, analytical standard
Mefenamic acid, European Pharmacopoeia (EP) Reference Standard
Mefenamic acid, United States Pharmacopeia (USP) Reference Standard
Mefenamicacid
Mefenaminic Acid
Mefenaminsaeure
Mefenaminsaeure [German]
Mefenaminsaure
Meftal (TN)
Mephadolor (TN)
Mephenamic acid
Mephenaminic acid
Methenamic acid
MFCD00051721
MLS000069709
MLS001074162
MolPort-001-839-968
Mycasaal
N-(2,3-Dimethylphenyl)anthranilic acid
N-(2,3-Xylyl)-2-aminobenzoic acid
N-(2,3-Xylyl)anthranilic acid
N-2,3-Xylylanthranilic acid
Namphen
NC00517
NCGC00016278-01
NCGC00016278-02
NCGC00016278-03
NCGC00016278-04
NCGC00016278-05
NCGC00016278-06
NCGC00016278-07
NCGC00016278-10
NCGC00022393-03
NCGC00022393-04
NCGC00022393-05
NCGC00255401-01
NINDS_000298
NSC 94437
NSC-757834
NSC-94437
NSC757834
NSC94437
Opera_ID_542
Oprea1_193889
OR057936
Parkemed
Parkemed (TN)
Pharmakon1600-01501103
Ponalar
Ponstal (TN)
Ponstan
Ponstan (TN)
Ponstan forte
Ponstel (TN)
Ponstel, Ponstan
Ponstil
Ponstyl
Pontal
Potarlon (TN)
Prestwick_506
Prestwick0_000054
Prestwick1_000054
Prestwick2_000054
Prestwick3_000054
Rolan
s4078
SAM002554908
SBB056999
SBI-0051636.P002
SC-16204
SCHEMBL3544
SGCUT00005
SMP2_000141
SMR000058188
SPBio_002001
SPBio_002128
Spectrum_000174
SPECTRUM1501103
Spectrum2_001941
Spectrum3_001082
Spectrum4_001235
Spectrum5_001341
SR-01000000216
SR-01000000216-2
ST086740
ST2409237
STK666691
Tamany Bonsan
Tanston
to_000071
Tox21_110344
Tox21_110344_1
Tox21_301983
UNII-367589PJ2C
UNM000001233403
Vialidon
W-105113
WLN: QVR BMR B1 C1
Z56755828
ZINC20241

US Patents and Regulatory Information for PONSTEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shionogi Inc PONSTEL mefenamic acid CAPSULE;ORAL 015034-003 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
Julphar
Queensland Health
McKesson
Mallinckrodt
Teva
Express Scripts
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.